Clinical Trial Update: A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

View source ↗

Summary

A multi-center, open-label prospective study evaluating early initiation of a targeted-release formulation of budesonide in patients with IgA nephropathy. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Budesonide targeted-release formulation (budesonide)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: IgA Nephropathy (IgAN), Early Initial Therapy | Status: RECRUITING